ClinicalTrials.gg
Not yet recruitingNCT06295510Updated Mar 6, 2024

Observational Study of the Association Between Food Intake and Endometrial Polyps

An observational study in Diet Habit, Endometrial Polyp and Women, sponsored by qinxiu zhang. Not yet recruiting. Open to female participants, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-03-06.

Sponsored by qinxiu zhang · Observational

From the registry’s dates

  • Primary completion was expected by Apr 2024, 2 years 7 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Case-control
Time perspective
Retrospective
Enrollment
150
Sex
Female
01

Study summary

There are currently no studies evaluating the association between diet and the incidence of endometrial polyps. We aim to evaluate the association to provide more recommendations for the early prevention of endometrial polyps.

Read the detailed description

The incidence of endometrial polyps is closely related to daily diet and living habits. Due to the excessive use of food additives, the content of some common dietary hormones exceeds the standard, causing irreversible effects on female growth and development.

The daily diet structure is closely related to women's health, and the enrichment of estrogen in common drinks may cause adverse effects such as premature puberty in women, abnormal thyroid function, and changes in uterine structure. Therefore, the researchers conducted a retrospective analysis of patients with endometrial polyps and normal women to compare the associations and differences between daily diet and disease.

02

Conditions studied

  • Diet Habit
  • Endometrial Polyp
  • Women

Browse trials for

Keywords

  • Diet
  • Endometrial polyp
  • Women
  • Milk tea
03

In context

Feeding Behavior

985 studies on the registry are indexed under Feeding Behavior; 178 are open to participants now.

This study's planned enrollment of 150 is below the median of 183 across 270 observational studies indexed under Feeding Behavior.

Browse Feeding Behavior studies →

Lead sponsor

qinxiu zhang is the lead sponsor of 3 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study period will include all patients who attended gynecological outpatient clinics between March 1, 2024 and May 1, 2024

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Consistent with the international clinical diagnosis of endometrial polyps.Can complete content recall alone.

Exclusion criteria

Exclusion Criteria:

  • No other mental diseases. Not associated with other major diseases, including tumors, immune system diseases
05

Study design

Observational model
Case-control
Time perspective
Retrospective
Enrollment
150 participants (estimated)
Patient registry
No

Groups and cohorts

  • healthy group (HG)

    Participants were grouped according to their basic conditions without any intervention. no intervention It's only observational study. No interventions.

    Other: No interventions.

  • case group(PG)

    Participants were grouped according to their basic conditions without any intervention. no intervention It's only observational study. No interventions.

    Other: No interventions.

Interventions

  • OtherNo interventions.

    It's only observational study.

06

What researchers measure

Primary outcomes

  1. Hormonal dietary intake

    Daily dietary intake questionnaire was used to evaluate.Weekly intake of milk tea, coffee, beverage, etc

    Time frame: Within the past 1 year

  2. Comparison of daily living habits

    Sleep, exercise, and other basic information were assessed based on a daily habits questionnaire.

    Time frame: Within the past 1 year

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No — Readers can access the survey data through a public data platform

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Mar 2024; primary completion for Apr 2024, 1 month later.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 22, 2024
First posted
Mar 6, 2024
StartEst.
Mar 1, 2024
Primary completionEst.
Apr 1, 2024
CompletionEst.
May 1, 2024
Last update
Mar 6, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 6, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06295510
Lead sponsor
qinxiu zhang
Responsible party
qinxiu zhang (Head of ENT, Chengdu University of Traditional Chinese Medicine) — Sponsor-investigator
First posted
Mar 6, 2024
Start date
Mar 1, 2024 (estimated)
Primary completion
Apr 1, 2024 (estimated)
Completion
May 1, 2024 (estimated)
Last update
Mar 6, 2024

Study contacts

Shi-Peng zhang
Contact
1343108750@qq.com
18702887822
qinxiu zhang
Contact
zhqinxiu@163.com
17738450679
Qinxiu Zhang
study director · Hospital of Chengdu University of Traditional Chinese Medicine

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion